BDI CO., LTD. (KOSDAQ:A148140) intends to acquire 51% stake in Eleison Pharmaceuticals Inc. for KRW 25 billion on July 3, 2020. BDI CO., LTD. (KOSDAQ:A148140) entered into an agreement to acquire 37.5% stake in Eleison Pharmaceuticals Inc. for KRW 13.4 billion on November 3, 2020. As per terms, BDI CO., LTD. will acquire 4.16 million shares of Eleison Pharmaceuticals Inc. As of November 11, 2020, BDI CO., LTD. will acquire 2.4 million shares of Eleison Pharmaceuticals Inc. For the year ended December 31, 2019, Eleison Pharmaceuticals Inc. reported total assets of KRW 73 million, net liabilities of KRW 15.73 billion, total sales of KRW 1.28 billion and net loss of KRW 1.90 billion. The transaction is expected to close on August 3, 2020. As per announcement of October 20, 2020, the transaction is expected to close on November 15, 2020. As of November 20, 2020, the transaction is expecetd to close on November 20, 2020.The acquisition will help the BDI to expand into a new business area and maximize its corporate value. Morgan, Lewis & Bockius LLP acted as legal advisor to Eleison Pharmaceuticals.